论文部分内容阅读
目的:观察益肺饮在联合介入治疗中对老年中晚期非小细胞肺癌血清D-二聚体、血清C反应蛋白(CRP)、癌胚抗原(CEA)的影响。方法:将60例老年中晚期非小细胞肺癌患者随机分成治疗组和对照组各30例,对照组采用单纯介入治疗,治疗组在对照组治疗基础上加服益肺饮,28d为1个疗程,连续服用2个疗程。结果:治疗组在降低患者血清D-二聚体、CRP、CEA水平方面均优于对照组,两组比较,差异有统计学意义(P<0.05)。结论:益肺饮联合介入治疗可在一定程度上改善老年中晚期非小细胞肺癌患者血液的高凝状态、降低肿瘤负荷,并有望达到改善预后、延长生存期的目的。
Objective: To observe the effects of Yifei drinking on serum D-dimer, serum C-reactive protein (CRP) and carcinoembryonic antigen (CEA) in elderly patients with advanced non-small cell lung cancer under combined interventional therapy. Methods: Sixty elderly patients with advanced non-small cell lung cancer were randomly divided into treatment group (n = 30) and control group (n = 30). The control group received simple interventional therapy. The treatment group received Yifei Yin on the basis of the control group. Take 2 courses continuously. Results: The treatment group was better than the control group in reducing the level of serum D-dimer, CRP and CEA, the difference was statistically significant (P <0.05). Conclusion: Yifei Decoction combined with interventional therapy can improve the hypercoagulability of blood in elderly patients with advanced non-small cell lung cancer to a certain extent, reduce the tumor burden, and is expected to achieve the purpose of improving prognosis and prolonging survival.